Biohit Oyj B-shares Subscribed with Stock Options I 2013

A total number of 5,000 new Biohit Oyj B-shares have been subscribed for with stock options I 2013 between 4 December 2018 and 11 February 2019.

Read more

Biohit Oyj: Managers’ Transactions

Biohit Plc – Managers’ transactions – Söderström Daniela

Read more

International group of experts revisits the value of traditional Helicobacter tests (13C urea breath test and stool antigen test) in their critical review

International group of multidisciplinary experts from China, Italy, Estonia and Finland, has written a comprehensive and critical review on advantages and limitations of the Helicobacter tests as screening tools of gastric cancer. This comprehensive review has been recently accepted for publication in a widespread international cancer journal (Anticancer Research), and it will appear in the next issue of the journal (1).

Read more

Business Development Director Lea Paloheimo will retire from Biohit Oyj

Biohit’s management team member Business Development Director Lea Paloheimo will retire as planned 31st of January 2019. Lea Paloheimo has been employed by Biohit since 2001.

Read more

Nicotine dependence is an increasing problem

Nicotine dependence is an increasing health problem even if smoking itself shows a declining trend. Nicotine-containing products frequently remain “on” even for years after smoking cessation.  The most recent innovation of Biohit Oyj, Acetium® lozenge – quit smoking- has been well received particularly among health care professionals because the product does not contain nicotine.

Read more

Biohit new-generation fecal immunochemical test (ColonView-FIT) is superior to traditional guaiac test in colorectal cancer screening

Biohit ColonView test is a new-generation fecal immunochemical test (FIT) designed for detection of fecal occult blood (FOB) in subjects participating in colorectal cancer (CRC) screening.

Read more

Chief Medical Director Kari Syrjänen will retire from Biohit Oyj

Biohit’s management team member Chief Medical Director Kari Syrjänen will retire as planned 31st of December 2018. Kari Syrjänen has been employed by Biohit since 2013.

read more

Biohit Oyj’s Financial Reporting and Annual General Meeting in 2019

Biohit Oyj will release its financial statements for 2018 …

Read more

Healthy Stomach Day aroused wide interest and increased awareness on stomach health

International Healthy Stomach Initiative (HSI) organized on Tuesday, October 2, 2018 in several countries all over the world public events aiming to increase the awareness on stomach health. As a part of this global initiative, a public event was organized in Helsinki, at Pörssitalo.

Read more